Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058616) titled 'Exploration of the effects of Shinrin-yoku (forest bathing) on health-related behavior and physiological measures' on July 28.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Open -but assessor(s) are blinded Control - No treatment

Primary Sponsor: Institute - HUMA R&D CORP

Condition: Condition - Healthy individuals Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To explore the effects of forest bathing on health-related behavior and physiological measures in healthy adult men Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Forest bathing - Washout - City-walking Interventions/Control_2 - City-walking - Washout - Forest bathing

Eligibility: Age-lower limit - 30 years-old = Gender - Male Key inclusion criteria - 1)Individuals who have given written consent to participate in this study 2)Males aged 30 to 59 when obtaining the consent 3)Individuals who are able to undergo prescreening, participate in city walking and forest bathing, consume the prescribed food, answer the questionnaire, wear Fitbit Inspire 3, have blood draws and stool collections, and remain at rest according to the schedule requested by the research personnel 4)Individuals who own a smartphone that can install the Fitbit app and who are able to agree to the terms of use of Fitbit Inspire 3 and the app 5)Individuals who have no problem with city walking and forest bathing walks 6)Individuals who exercise at least once a week 7)Individuals with a T score of 30 or greater and less than 70 on the Profile of Mood States-Second Edition (POMS2) test during prescreening Key exclusion criteria - 1)Individuals who were deemed ineligible for this study by the principal investigator based on the results of the preliminary examination 2)Individuals who currently have or previously had gastrointestinal, cardiovascular, endocrine, inflammatory (immunological), neuropsychiatric, or other diseases; individuals who regularly use drugs to treat diseases and are considered unsuitable to participate in this study by the principal investigator; individuals on antibiotics, anti-inflammatory drugs, anti-allergic drugs, steroids, immunosuppressants, etc.; and individuals with a common cold 3)Individuals considered to have difficulty in wearing Fitbit Inspire 3 4)Individuals who plan to stay overseas with overnight accommodation between the preliminary examination and follow-up examination 5)Individuals with food allergy 6)Individuals with smoking habits 7)Individuals with an intense fear of or an aversion to insects and reptiles such as snakes 8)Individuals who donated blood within 12 weeks prior to the preliminary examination 9)Individuals who are currently participating in another study or are scheduled to participate in one during the intervention period 10)Individuals who are estimated inappropriate by principal investigator or study director Target Size - 24

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 07 Month 03 Day Date of IRB - 2025 Year 07 Month 11 Day Anticipated trial start date - 2025 Year 07 Month 29 Day Last follow-up date - 2025 Year 09 Month 19 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067000

Disclaimer: Curated by HT Syndication.